JPS5013333B1 - - Google Patents

Info

Publication number
JPS5013333B1
JPS5013333B1 JP3527470A JP3527470A JPS5013333B1 JP S5013333 B1 JPS5013333 B1 JP S5013333B1 JP 3527470 A JP3527470 A JP 3527470A JP 3527470 A JP3527470 A JP 3527470A JP S5013333 B1 JPS5013333 B1 JP S5013333B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3527470A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP3527470A priority Critical patent/JPS5013333B1/ja
Priority to FR7111805A priority patent/FR2092068B1/fr
Priority to IT2272771A priority patent/IT1001467B/it
Priority to CA110,999A priority patent/CA955850A/en
Priority to BE766093A priority patent/BE766093A/xx
Priority to CH589371A priority patent/CH563459A5/xx
Priority to GB1085371A priority patent/GB1349362A/en
Priority to DE2119688A priority patent/DE2119688C3/de
Priority to NL7105497A priority patent/NL173598C/xx
Publication of JPS5013333B1 publication Critical patent/JPS5013333B1/ja
Priority to NL8303134A priority patent/NL8303134A/nl
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP3527470A 1970-04-22 1970-04-22 Pending JPS5013333B1 (fi)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP3527470A JPS5013333B1 (fi) 1970-04-22 1970-04-22
FR7111805A FR2092068B1 (fi) 1970-04-22 1971-04-02
IT2272771A IT1001467B (it) 1970-04-22 1971-04-03 Procedimento per la preparazione di una coltura contro effetti da virus
CA110,999A CA955850A (en) 1970-04-22 1971-04-21 Process for preparing live virus vaccines
CH589371A CH563459A5 (fi) 1970-04-22 1971-04-22
BE766093A BE766093A (fr) 1970-04-22 1971-04-22 Procede de preparation de vaccins actifs viraux
GB1085371A GB1349362A (en) 1970-04-22 1971-04-22 Process for preparing live virus vaccines
DE2119688A DE2119688C3 (de) 1970-04-22 1971-04-22 Herstellung von Impfstoffen mit lebenden Viren
NL7105497A NL173598C (nl) 1970-04-22 1971-04-22 Werkwijze ter bereiding van een levend vaccin tegen kippeziekte.
NL8303134A NL8303134A (nl) 1970-04-22 1983-09-09 Werkwijze voor de bereiding van een levend virusvaccin onder toepassing van kwarteleieren of kwartelembryofibroblasten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3527470A JPS5013333B1 (fi) 1970-04-22 1970-04-22

Publications (1)

Publication Number Publication Date
JPS5013333B1 true JPS5013333B1 (fi) 1975-05-19

Family

ID=12437194

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3527470A Pending JPS5013333B1 (fi) 1970-04-22 1970-04-22

Country Status (9)

Country Link
JP (1) JPS5013333B1 (fi)
BE (1) BE766093A (fi)
CA (1) CA955850A (fi)
CH (1) CH563459A5 (fi)
DE (1) DE2119688C3 (fi)
FR (1) FR2092068B1 (fi)
GB (1) GB1349362A (fi)
IT (1) IT1001467B (fi)
NL (2) NL173598C (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA743771B (en) * 1973-07-19 1975-07-30 M Sevoian Vaccine and preparation thereof

Also Published As

Publication number Publication date
NL8303134A (nl) 1984-01-02
NL173598C (nl) 1984-02-16
NL7105497A (fi) 1971-10-26
BE766093A (fr) 1971-09-16
DE2119688A1 (de) 1971-11-04
DE2119688C3 (de) 1980-04-24
CA955850A (en) 1974-10-08
FR2092068B1 (fi) 1977-04-15
DE2119688B2 (de) 1979-08-09
NL173598B (nl) 1983-09-16
GB1349362A (en) 1974-04-03
FR2092068A1 (fi) 1972-01-21
IT1001467B (it) 1976-04-20
CH563459A5 (fi) 1975-06-30

Similar Documents

Publication Publication Date Title
AR204384A1 (fi)
ATA96471A (fi)
AU1146470A (fi)
AU2044470A (fi)
AU1473870A (fi)
JPS5013333B1 (fi)
AU2017870A (fi)
AU1326870A (fi)
AU1833270A (fi)
AU1716970A (fi)
AU1336970A (fi)
AU1517670A (fi)
AU2085370A (fi)
AU2130570A (fi)
AR195465A1 (fi)
AU1189670A (fi)
AU1832970A (fi)
AU1064870A (fi)
AU1004470A (fi)
AU1086670A (fi)
ATA672271A (fi)
AU1881070A (fi)
AU2119370A (fi)
AU2115870A (fi)
AU1918570A (fi)